This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Medtronic, Inc., Sanofi-A Ventis Deutschland Gmbh. Active years: 2010-2012.
Company Filing History:
Years Active: 2010-2012
Title: Maurits Allessie: Innovator in Cardiac Treatment
Introduction
Maurits Allessie is a notable inventor based in Maastricht, Netherlands. He has made significant contributions to the field of cardiac treatment, particularly in the development of innovative therapies for atrial arrhythmias. With a total of 2 patents, Allessie has demonstrated his commitment to advancing medical science.
Latest Patents
Allessie's latest patents include a combination of phenylcarboxamides with blockers of the IKr channel and their use for the treatment of atrial arrhythmias. This invention focuses on the combination of one or more IK channel blockers and Kv1.5 blockers, specifically phenyl-carboxamides, and their application in treating atrial arrhythmias. Another significant patent involves methods and apparatus for preventing early recurring atrial fibrillation and atrial flutter episodes. This disclosure outlines a strategy for commencing atrial overdrive pacing therapy upon detecting an AF episode or a long pause between successive sensed P-waves during an AF episode.
Career Highlights
Throughout his career, Maurits Allessie has worked with prominent companies in the medical field, including Sanofi-Aventis Deutschland GmbH and Medtronic, Inc. His experience in these organizations has contributed to his expertise in developing innovative cardiac therapies.
Collaborations
Allessie has collaborated with notable professionals in his field, including Joachim Brendel and Klaus Wirth. These partnerships have likely enhanced his research and development efforts.
Conclusion
Maurits Allessie is a distinguished inventor whose work in cardiac treatment has the potential to significantly impact patient care. His innovative patents and collaborations reflect his dedication to improving medical therapies for atrial arrhythmias.